Recurrence risk factors are influenced by age, early stages, tumor biological backgrounds, tumor size, lymph node involvement, histological grade, lymphovascular invasion, hormone receptor, HER-2 and menopause status [10]. This evidence concerns the gene ERBB2 and neoplasm.